Oncoinvent is a privately held Norwegian radiopharmaceuticals company, founded in 2010 by Roy Larsen and Øyvind Bruland, who also founded Algeta, Nordic Nanovector and Artbio. Algeta made it to the headlines in 2013 when it was acquired by Bayer for USD 2.9 billion.